Ruthenium
carbenes, famously used in olefin metathesis, have impacted
numerous research areas, ranging from synthesis to materials and biology.
Although in the same group as ruthenium, iron carbenes showing similar
reaction patterns have not been reported. Such targets are of high
interest because the use of a sustainable metal would lead to a decreased
cost, toxicity, and environmental impact of the corresponding compounds.
Herein, we report the synthesis of an iron carbene complex, [{PC(sp2)P}Fe(N2)(PMe3)] ([PC(sp2)P] = (bis[2-(di-isopropylphosphino)phenyl]methylene),
which is capable of performing [2+2] cycloaddition reactions in the
presence of alkynes. Specifically, η3-vinyl carbenes
are formed stoichiometrically through a [2+2] cycloaddition between
the alkyne and the metal carbene. Additional reactivity of the η3-vinyl carbenes with alkynes yields a second insertion product
containing a new iron carbene moiety.
A series
of palladium pincer complexes supported by (
i
Pr2P-C6H4)2CH2 (PC(sp3)H2P = bis(2-(diisopropylphosphanyl)phenyl)methane)
was isolated and characterized. Different modes of C–H activation
were observed for [{PC(sp3)H2P}PdX2] (X = Cl, OTf, Me, OAc). The thermal treatment of [{PC(sp3)H2P}PdX2] (X = Cl, OTf) induced a backbone
C–H bond activation to generate the respective [{PC(sp3)HP}PdX] complex, while under similar reaction conditions
[{PC(sp3)H2P}PdMe2] underwent a C–C
reductive elimination that led to the formation of a Pd(0) dimer,
[{PC(sp3)H2P}Pd]2. For the analogous
diacetate complex [{PC(sp3)H2P}Pd(OAc)2], the C–H activation occurred at the phosphine isopropyl
methine group to generate a palladacycle.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.